Human miR-128a has been associated with breast cancer aggressiveness [203] and was predicted to target the TGF-β signaling pathways members (TGF-β receptor I (TGFβRI) and the transcription factor SMAD2) [204]. This evidence concerns the gene TGFB1 and breast carcinoma.